Skip to main content

$0.016 0.001 (6.67%)

High

$0.02

Low

$0.02

Trades

65

Turnover

$89,903

Volume

5,525,026
30 June 2023 at 4:10pm
Register to track IBX and receive email alerts.
Subject
IBX Ann: Non-renounceable Entitlement Offer

IBX Ann: Imagion Secures Growth Funding

IBX Ann: Imagion Funding Update

IBX Ann: Imagion receives 2nd CSIRO grant for prostate cancer project

IBX Ann: Appendix 4G and Corporate Governance Statement

IBX Ann: 2022 Annual Report to Shareholders

IBX Ann: Appendix 4E

IBX Ann: Investor Webinar Participation

IBX Ann: Investor Webinar Recording

IBX Ann: Investor Webinar

IBX Ann: Investor Presentation

IBX Ann: Company Update - Phase 1 Study Independent Review

IBX Ann: Quarterly Activities/Appendix 4C Cash Flow Report

IBX Ann: Notification regarding unquoted securities - IBX

IBX Ann: Positive clinical data reported at breast cancer symposium

IBX Ann: Change of Registry Address

IBX Ann: Notification regarding unquoted securities - IBX

IBX Ann: Quarterly Activities/Appendix 4C Cash Flow Report

IBX Ann: 2021 R&D Tax Refund

IBX Ann: Prostate cancer research update

IBX Ann: Change of Director's Interest Notice

IBX Ann: Notification regarding unquoted securities - IBX

IBX Ann: Half-Year Results Release

IBX Ann: Half-Year Investor Presentation

IBX Ann: Half-Year Financial Report

IBX Ann: Appendix 4D

IBX Ann: Notification regarding unquoted securities - IBX

IBX Ann: Application for quotation of securities - IBX

IBX Ann: Notification of cessation of securities - IBX

IBX Ann: Quarterly Activities/Appendix 4C Cash Flow Report

IBX Ann: Results of Meeting

IBX Ann: Chairman's Address to Shareholders AGM

IBX Ann: AGM presentation

IBX Ann: Quarterly Activities/Appendix 4C Cash Flow Report

IBX Ann: Notice of Annual General Meeting/Proxy Form

IBX Ann: Imagion Biosystems April 2022 Investor Newsletter

IBX Ann: Notification regarding unquoted securities - IBX

IBX Ann: Issue of unlisted options under Equity Incentive Plan

IBX Ann: First-in-human Study Progress Update

IBX Ann: Revised Appendix 4G

IBX Ann: Full Year Results Release

IBX Ann: Full Year Investor Presentation

IBX Ann: Appendix 4G and Corporate Governance Statement

IBX Ann: 2021 Annual Report to Shareholders

IBX Ann: Appendix 4E

IBX Ann: Notification regarding unquoted securities - IBX

IBX Ann: Issue of unlisted options under Equity Incentive Plan

IBX Ann: Quarterly Activities/Appendix 4C Cash Flow Report

IBX Ann: Application for quotation of securities - IBX

IBX Ann: Cleansing Notice under Section 708A

Register to track IBX and receive email alerts.

Similar Companies

AT1
COH
CSX
CYC
EMV
IPD
MX1
RSH
SOM